Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
UMC Utrecht
Essen Biotech
Jonsson Comprehensive Cancer Center
xCures
University of Nebraska
Adela, Inc
Var2 Pharmaceuticals
Mayo Clinic
M.D. Anderson Cancer Center
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
University of Arizona
Day One Biopharmaceuticals, Inc.
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Telix Pharmaceuticals (Innovations) Pty Limited
Tempus AI